GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide-copper complex first identified in human plasma by Dr. Loren Pickart in 1973. It consists of three amino acids — glycine, histidine, and lysine — with a high binding affinity for copper(II) ions. GHK-Cu is present in human plasma at approximately 200ng/ml in young adults, but its concentration declines significantly with age, dropping to approximately 80ng/ml by age 60. This age-related decline correlates directly with the progressive deterioration of tissue repair capacity, skin quality, and wound healing rates.

At the molecular level, GHK-Cu is a gene expression modulator of remarkable breadth. Genome-wide studies have identified over 4,000 genes whose expression is significantly altered by GHK-Cu. It upregulates genes involved in collagen synthesis (types I, III, and V), glycosaminoglycan production, decorin expression, and metalloproteinase inhibitors (TIMPs) while simultaneously downregulating inflammatory mediators and pro-fibrotic signals. The copper ion is essential: it serves as a cofactor for lysyl oxidase, the enzyme responsible for collagen and elastin crosslinking, and for superoxide dismutase, a critical antioxidant enzyme. GHK-Cu also stimulates fibroblast proliferation, promotes angiogenesis, and recruits immune cells to wound sites in a coordinated manner that promotes regenerative healing over scar formation.

Research has documented GHK-Cu's effects across skin rejuvenation, wound healing, hair follicle stimulation, lung tissue repair, and bone regeneration. In dermatological research, it has demonstrated increases in skin thickness, density, and elasticity comparable to retinoic acid but without the irritation. It promotes production of both collagen and the dermal matrix components (proteoglycans, glycosaminoglycans) that give skin its structural hydration. Studies in wound healing models show accelerated closure rates, increased angiogenesis, and reduced scarring. Its antioxidant properties — both direct (SOD upregulation) and indirect (free radical scavenging) — position it as one of the most comprehensive anti-aging peptides available to researchers.

GHK-Cu is ideally suited for researchers investigating dermal regeneration, wound healing acceleration, anti-aging interventions, post-procedure skin recovery, and hair regrowth. It is one of the few peptides with robust research support for both injectable (systemic) and topical (local) administration routes.

The 50mg vial offers substantial supply for extended protocols. For injection research, reconstitute with bacteriostatic water and administer subcutaneously at 1-3mg per day. For topical research applications, GHK-Cu can be incorporated into carrier creams at 0.01-1% concentration. Reconstituted solution should be stored at 2-8C. GHK-Cu has a relatively short plasma half-life, supporting daily administration for injectable protocols. The copper complex is stable in lyophilized form at room temperature but should be refrigerated for long-term storage.